Carbamoyl phosphate, biosynthesis

Alcantara, C. Cervera, J. Rubio, V. Carbamate kinase can replace in vivo carbamoyl phosphate synthetase. Implications for the evolution of carbamoyl phosphate biosynthesis. FEBS Lett., 484, 261-264 (2000)... 

Durbecq, V., Legrain, C., Roovers, M., Pierard, A., and Glansdorff, N. (1997). The carbamate kinase-like carbamoyl phosphate synthetase of the hyperthermophilic archaeon Pyrococcus fa nos us. a missing link in the evolution of carbamoyl phosphate biosynthesis. Proc. Natl. Acad. Sci. USA, 94, 12803-12808. 

Consider carbamoyl phosphate, a precursor in the biosynthesis of pyrimidines ... 

One of the steps in the biosynthesis of uridine monophosphate is the reaction of aspartate with carbamoyl phosphate to give carbamoyl aspartate followed by cyclization to form dihydroorotate. Propose mechanisms for both steps. 

Carbamoyl Phosphate Synthase I Initiates Urea Biosynthesis... 

Condensation of CO2, ammonia, and ATP to form carbamoyl phosphate is catalyzed by mitochondrial carbamoyl phosphate synthase I (reaction 1, Figure 29-9). A cytosolic form of this enzyme, carbamoyl phosphate synthase II, uses glutamine rather than ammonia as the nitrogen donor and functions in pyrimidine biosynthesis (see Chapter 34). Carbamoyl phosphate synthase I, the rate-hmiting enzyme of the urea cycle, is active only in the presence of its allosteric activator JV-acetylglutamate, which enhances the affinity of the synthase for ATP. Formation of carbamoyl phosphate requires 2 mol of ATP, one of which serves as a phosphate donor. Conversion of the second ATP to AMP and pyrophosphate, coupled to the hydrolysis of pyrophosphate to orthophosphate, provides the driving... 

Changes in enzyme levels and allosteric regulation of carbamoyl phosphate synthase by A -acetylglutamate regulate urea biosynthesis. 

Figure 34-7 summarizes the roles of the intermediates and enzymes of pyrimidine nucleotide biosynthesis. The catalyst for the initial reaction is cytosolic carbamoyl phosphate synthase II, a different enzyme from the mitochondrial carbamoyl phosphate synthase I of urea synthesis (Figure 29-9). Compartmentation thus provides two independent pools of carbamoyl phosphate. PRPP, an early participant in purine nucleotide synthesis (Figure 34-2), is a much later participant in pyrimidine biosynthesis.

Five of the first six enzyme activities of pyrimidine biosynthesis reside on multifunctional polypeptides. One such polypeptide catalyzes the first three reactions of Figure 34-2 and ensures efficient channeling of carbamoyl phosphate to pyrimidine biosynthesis. A second bifunctional enzyme catalyzes reactions 5 and 6. 

Excess carbamoyl phosphate exits to the cytosol, where it stimulates pyrimidine nucleotide biosynthesis. The resulting mild orotic aciduria is increased by high-nitrogen foods. 

Since pyrimidine catabolites are water-soluble, their overproduction does not result in clinical abnormalities. Excretion of pyrimidine precursors can, however, result from a deficiency of ornithine transcar-bamoylase because excess carbamoyl phosphate is available for pyrimidine biosynthesis. 

ATCase catalyzes the first step in the biosynthesis of cytidine triphosphate (CTP). The sequence of reactions leading from the reactants, aspartate and carbamoyl phosphate, to CTP is shown in Fig. 8.19. 

The liver also receives some ammonia via the portal vein from the intestine, from the bacterial oxidation of amino acids. Whatever its source, the Nib generated in liver mitochondria is immediately used, together with C02 (as HCO3) produced by mitochondrial respiration, to form carbamoyl phosphate in the matrix (Fig. 18-1 la see also Fig. 18-10). This ATP-dependent reaction is catalyzed by carbamoyl phosphate synthetase I, a regulatory enzyme (see below). The mitochondrial form of the enzyme is distinct from the cytosolic (II) form, which has a separate function in pyrimidine biosynthesis (Chapter 22). 

The common pyrimidine ribonucleotides are cytidine 5 -monophosphate (CMP cytidylate) and uridine 5 -monophosphate (UMP uridylate), which contain the pyrimidines cytosine and uracil. De novo pyrimidine nucleotide biosynthesis (Fig. 22-36) proceeds in a somewhat different manner from purine nucleotide synthesis the six-membered pyrimidine ring is made first and then attached to ribose 5-phosphate. Required in this process is carbamoyl phosphate, also an intermediate in the urea cycle (see Fig. 18-10). However, as we noted... 

FIGURE 22-36 De novo synthesis of pyrimidine nucleotides biosynthesis of UTP and CTP via orotidylate. The pyrimidine is constructed from carbamoyl phosphate and aspartate. The ribose 5-phosphate is then added to the completed pyrimidine ring by orotate phosphori-bosyltransferase. The first step in this pathway (not shown here see Fig. 18-11a) is the synthesis of carbamoyl phosphate from C02 and NH), catalyzed in eukaryotes by carbamoyl phosphate synthetase II. 

Biosynthesis of UMP. The parts of the intermediates derived from aspartate are shown in red. Bold type indicates atoms derived from carbamoyl phosphate. In contrast to purine nucleotide synthesis, where ring formation starts on the sugar, in pyrimidine biosynthesis the pyrimidine ring is completed before being attached to the ribose. 

In eukaryotes, carbamoyl phosphate synthase is inhibited by pyrimidine nucleotides and stimulated by purine nucleotides it appears to be the most important site of feedback inhibition of pyrimidine nucleotide biosynthesis in mammalian tissues. It has been suggested that under some conditions, orotate phosphoribosyltransferase may be a regulatory site as well. 

How do you explain the observation that pyrimidine biosynthesis in bacteria is regulated at the level of aspartate carbamoyltransferase, whereas most of the regulation in humans is at the level of carbamoyl phosphate synthase ... 

Carbamoyl phosphate synthase contributes to two processes (a) the initial enzyme in the biosynthesis of pyrimidines and (b) a component in the synthesis of arginine biosynthesis or the urea cycle. In bacteria both of these processes occur within the same compartment. In human beings the carbamoyl phosphate synthase involved in the urea cycle is contained in... 

Figure 7.6 (a) The first step in the biosynthesis of pyrimidines, (b) The proposed transition state for the carbamoyl phosphate/aspartic acid stage in pyrimidine synthesis, (c) The structure of sodium N-phosphonoacetyl-L-aspartate (PALA)... 

Aspartate transcarbamoylase (aspartate carbamoyltransferase ATCase), a key enzyme in pyrimidine biosynthesis (see Topic FI), provides a good example of allosteric regulation. ATCase catalyzes the formation of N-carbamoylaspar-tate from aspartate and carbamoyl phosphate, and is the committed step in pyrimidine biosynthesis (Fig. 2). The binding of the two substrates aspartate and carbamoyl phosphate is cooperative, as shown by the sigmoidal curve of V0 against substrate concentration (Fig. 3). 

Unlike in purine biosynthesis, the pyrimidine ring is synthesized before it is conjugated to PRPP. The first reaction is the conjugation of carbamoyl phosphate and aspartate to make N-carbamoylaspartate. The carbamoyl phosphate synthetase used in pyrimidine biosynthesis is located in the cytoplasm, in contrast to the carbamoyl phosphate used in urea synthesis, which is made in the mitochondrion. The enzyme that carries out the reaction is aspartate transcarbamoylase, an enzyme that is closely regulated. 

The design for pyrimidine synthesis differs somewhat from that of purine biosynthesis in that the sugar is attached to the pyrimidine ring at the end of the pathway. In addition, pyrimidine biosynthesis occurs in part in the cytosol and in part in the mitochondria and involves the participation of two multifunctional enzymes. The pathway is summarized in Figure 10.9. One of the initial reactants is the compound carbamoyl phosphate (carbamoyl phosphoric acid). This compound is also formed in the urea biosynthetic pathway, but this takes place in the mitochondria and requires NH3 (Chapter 20). The cytosolic biosynthesis of carbamoyl phosphate for the purpose of pyrimidine biosynthesis requires glutamine as the nitrogen donor ... 

Figure 10.9 De now pyrimidine nucleotide biosynthesis pathway. Note the numbering of the pyrimidine ring in UMP atoms 2 and 3 come from carbamoyl phosphate and atoms 1, 4, 5, and 6 from aspartate.

Carbamoyl phosphate synthetase is part of a multifunctional enzyme that catalyzes the first three steps in pyrimidine biosynthesis. 

Aspartate carbamoyltransferase catalyzes the formation of carbamoyl aspartate from carbamoyl phosphate and aspartate in the first committed step of pyrimidine biosynthesis (Chap. 15). The enzyme from the bacterium E. coli (Mr = 310,000) consists of 12 subunits, six regulatory and six catalytic. CTP is a negative effector i.e., it inhibits the enzyme, and does so through binding to the regulatory subunits. ATP is a positive effector that acts through the regulatory subunits, while succinate inhibits the reaction by direct competition with aspartate at the active site (see Chap. 9 for more on effectors). 

The atoms of the pyrimidine ring are derived from carbamoyl phosphate and aspartate, as shown in Fig. 15-14. The de novo biosynthesis of pyrimidine nucleotides is shown in Fig. 15-15. The first completely formed pyrimidine ring is that of dihydroorotate. Only after oxidation to orotate is the ribose attached to produce orotidylate. The compound 5-phosphoribosyl 1-pyrophosphate (P-Rib-PP) provides the ribose phosphate. L-Glutamine is used as a substrate donating nitrogen atoms at reactions 1 and 9, catalyzed by carbamoyl phosphate synthetase II and CTP synthetase, respectively a second... 

There are two multifunctional proteins in the pathway for de novo biosynthesis of pyrimidine nucleotides. A trifunctional protein, called dihydroorotate synthetase (or CAD, where the letters are the initials of the three enzymatic activities), catalyzes reactions 1, 2 and 3 of the pathway (HCC>5"- CAP— CA-asp—> DHO Fig. 15-15). The enzymatic activities of carbamoyl phosphate synthetase, aspartate transcarbamoylase and dihydroorotase, are contained in discrete globular domains of a single polypeptide chain of 243 kDa, where they are covalently connected by segments of polypeptide chain whch are susceptible to digestion by proteases such as trypsin. A bifunctional enzyme, UMP synthase, catalyzes reactions 5 and 6 of the pyrimidine pathway (orotate— OMP—> UMP Fig. 15-15). Two enzymatic activities, those of orotate phosphoribosyltransferase and OMP decarboxylase, are contained in a single protein of 51.5 kDa which associates as a dimer. 

Dihydroorotate dehydrogenase, the enzyme catalyzing the dehydrogenation of dihydroorotate to orotate (reaction 4 of the pathway Fig. 15-15), is located on the outer side of the inner mitochondrial membrane. This enzyme has FAD as a prosthetic group and in mammals electrons are passed to ubiquinone. The de novo pyrimidine pathway is thus compartmentalized dihydroorotate synthesized by trifunctional DHO synthetase in the cytosol must pass across the outer mitochondrial membrane to be oxidized to orotate, which in turn passes back to the cytosol to be a substrate for bifunctional UMP synthase. Mammalian cells contain two carbamoyl phosphate synthetases the glutamine-dependent enzyme (CPSase II) which is part of CAD, and an ammonia-dependent enzyme (CPSase /) which is found in the mitochondrial matrix, and which is used for urea and arginine biosynthesis. Under certain conditions (e.g., hyperammonemia), carbamoyl phosphate synthesized in the matrix by CPSase I may enter pyrimidine biosynthesis in the cytosol. 

The biosynthesis of uracil proceeds via decarboxylation of orotidin-5 -phosphate, which is formed from carbamoyl phosphate and aspartate via orotate after nucleosidation with 5-phosphoribosyl-l-diphosphate. Uracil can also be generated from cytosine by oxidative deamination using sodium hydrogensulfite. 

---